Welcome to our dedicated page for Markel Corporation SEC filings (Ticker: MKL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Markel Group Inc. filings document the financial reporting, governance, and capital-structure disclosures of a diversified holding company centered on specialty insurance. Its regulatory record includes 8-K reports for annual and quarterly results, Regulation FD materials such as shareholder letters, leadership and compensation changes, and reporting changes tied to business re-segmentation.
Proxy filings describe board matters, executive compensation, shareholder voting items, and equity-award disclosures. Other filings address registered securities and plan-interest matters, including Costa Farms LLC 401(k) Plan disclosures, while preserving Markel Group’s continuing reporting obligations for its common shares.
An insider of MKL filed a Rule 144 notice to sell 100 common shares through Fidelity Brokerage Services LLC on the NYSE. The shares to be sold have an aggregate market value of 210000.00, while total common shares outstanding are 12,610,250.
The planned sale date is approximately 11/28/2025. The 100 shares were originally acquired as founder shares on 05/25/2010 from the issuer as compensation. During the past three months, Steven A. Markel sold 70 common shares on 11/26/2025 for gross proceeds of 147000.00, and these transactions are disclosed in connection with the Rule 144 requirements.
Markel Group Inc. insider transaction reported for MKL. Reporting person Simon Wilson, who serves as CEO of Markel Insurance, filed a Form 4 for a sale of Markel Group Inc. common stock. On 11/25/2025, Wilson sold 75 shares of common stock at a price of $2,072.94 per share, coded as an open market or similar sale. After this transaction, he beneficially owns 1,769.6286 shares of Markel Group Inc. common stock in direct ownership form.
Markel Group Inc. director Steven A. Markel reported a change in his ownership of MKL common stock. On 11/17/2025, he disposed of 500 shares of common stock at a reported price of $0 under transaction code G, and held 61,868 shares directly afterward. He also held 2,060.699 shares indirectly through the MKL 401(k) plan and 15,000 shares indirectly through his spouse, for which beneficial ownership is expressly disclaimed. The 401(k) balance includes 1.169 shares acquired between March 31, 2025 and September 30, 2025.
Markel Group Inc. filed a Form 13F disclosing institutional holdings reported by its investment manager. The report lists 208 reported positions with a total reported market value of $12,320,986,843. The filing names Markel-Gayner Asset Management LLC as an additional included manager.
Markel Group Inc. (MKL) furnished an update on its 2025 third quarter and nine‑months results via a press release attached to an 8‑K. The company also outlined reporting changes, including a re‑segmentation of its businesses and expanded consolidated and segment metrics.
To help readers compare periods, Markel furnished supplemental recast quarterly financial information as Exhibit 99.2. A Reporting Changes Guide (Exhibit 99.3) explains the new structure and disclosures and is also available at ir.mklgroup.com. These materials are intended to clarify the company’s updated presentation alongside the latest quarterly results.
Markel Group Inc. reported third-quarter 2025 results. Total operating revenues were $3.934 billion, up from $3.694 billion a year ago, as earned premiums reached $2.206 billion and services and other revenues grew to $875.6 million. Operating income was $1.010 billion.
Profitability eased year over year. Net income to common shareholders was $751.3 million versus $905.0 million, with diluted EPS of $59.25 versus $66.25. Net investment gains were $432.9 million compared with $917.5 million last year, and foreign exchange moved to a $19.3 million gain from a $111.6 million loss. The company’s accumulated other comprehensive loss improved to $(138.97) million as unrealized losses narrowed.
Balance sheet and cash flow remained strong. Total assets were $67.39 billion and shareholders’ equity was $18.04 billion. Net cash provided by operating activities for the nine months was $2.099 billion. Year to date, the company redeemed $600 million of preferred stock and repurchased $344.0 million of common stock. Markel reorganized segments and, in August 2025, sold renewal rights for its Global Reinsurance division; premiums from prior multi‑year contracts will continue earning over the next two to three years.
Markel Group (MKL) reported insider activity by its CFO, Brian J. Costanzo. On September 30, 2025, he acquired 1.846 shares of common stock under the MKL 2020 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c) at a price of $1,624.66 per share.
Following the transaction, Costanzo beneficially owned 976.0816 shares directly and 223.838 shares indirectly through the MKL 401(k) plan. The 401(k) plan balance reflects an additional 2.136 shares acquired between June 30, 2025 and September 30, 2025.
Meade P. Grandis, Chief Accounting Officer and Controller of Markel Group Inc. (MKL), reported a sale on 08/25/2025 of 75 shares of Markel common stock for $1,983.78 as shown on this Form 4. The filing lists multiple categories of beneficial ownership across trusts, retirement plan and family members, including entries labeled "By Trusts," a 401(k) plan balance, an irrevocable trust, and holdings attributed to spouse, daughter and son. Explanatory footnotes describe the spouse’s role as co-trustee and a distribution of 3,569.5 shares from the trusts to the spouse; plan share details reflect the 401(k) balance as of June 30, 2025. The form is signed by an attorney-in-fact on behalf of the reporting person.